1. “Immunosenescence: Aging and Immune System Decline”
by Priyanka Goyani, Rafail Christodoulou and Evros Vassiliou
Vaccines 2024, 12(12), 1314; https://doi.org/10.3390/vaccines12121314
Full text available online: https://www.mdpi.com/2076-393X/12/12/1314

2. “Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters”
by Emmanouil Karampinis, Myrto-Maria Papadopoulou, Kleoniki Chaidaki, Konstantina-Eirini Georgopoulou, Stavroula Magaliou, Angeliki Viktoria Roussaki Schulze, Dimitrios P. Bogdanos and Efterpi Zafiriou
Vaccines 2024, 12(2), 178; https://doi.org/10.3390/vaccines12020178
Full text available online: https://www.mdpi.com/2076-393X/12/2/178

3. “Vaccines for the Elderly and Vaccination Programs in Europe and the United States”
by Cleo Anastassopoulou, Stefanos Ferous, Snežana Medić, Nikolaos Siafakas, Fotini Boufidou, Georgia Gioula and Athanasios Tsakris
Vaccines 2024, 12(6), 566; https://doi.org/10.3390/vaccines12060566
Full text available online: https://www.mdpi.com/2076-393X/12/6/566

4. “Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies”
by Palaniyandi Muthukutty, Jaime MacDonald and So Young Yoo
Vaccines 2024, 12(11), 1220; https://doi.org/10.3390/vaccines12111220
Full text available online: https://www.mdpi.com/2076-393X/12/11/1220

5. “Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy”
by Brunella Perfetto, Giovanna Paduano, Elena Grimaldi, Vincenza Sansone, Giovanna Donnarumma and Gabriella Di Giuseppe
Vaccines 2024, 12(3), 335; https://doi.org/10.3390/vaccines12030335
Full text available online: https://www.mdpi.com/2076-393X/12/3/335

6. “Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants”
by Angelika Wagner, Erika Garner-Spitzer, Claudia Auer, Pia Gattinger, Ines Zwazl, René Platzer, Maria Orola-Taus, Peter Pichler, Fabian Amman, Andreas Bergthaler et al.
Vaccines 2024, 12(5), 518; https://doi.org/10.3390/vaccines12050518
Full text available online: https://www.mdpi.com/2076-393X/12/5/518

7. “T Cell Responses during Human Immunodeficiency Virus/Mycobacterium tuberculosis Coinfection”
by José Alejandro Bohórquez, Chinnaswamy Jagannath, Huanbin Xu, Xiaolei Wang and Guohua Yi
Vaccines 2024, 12(8), 901; https://doi.org/10.3390/vaccines12080901
Full text available online: https://www.mdpi.com/2076-393X/12/8/901

8. “Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2”
by Achilleas Livieratos, Lars Erik Schiro, Charalambos Gogos and Karolina Akinosoglou
Vaccines 2024, 12(12), 1444; https://doi.org/10.3390/vaccines12121444
Full text available online: https://www.mdpi.com/2076-393X/12/12/1444

9. “Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines”
by Kacy S. Yount and Toni Darville
Vaccines 2024, 12(8), 863; https://doi.org/10.3390/vaccines12080863
Full text available online: https://www.mdpi.com/2076-393X/12/8/863

10. “Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model”
by Kyu-Ri Kang, Ji-Ahn Kim, Gyu-Won Cho, Han-Ul Kang, Hyun-Mi Kang, Jin-Han Kang, Baik-Lin Seong and Soo-Young Lee
Vaccines 2024, 12(1), 108; https://doi.org/10.3390/vaccines12010108
Full text available online: https://www.mdpi.com/2076-393X/12/1/108